Proficio Capital Partners LLC Invests $5.18 Million in VanEck Biotech ETF $BBH

Proficio Capital Partners LLC purchased a new position in VanEck Biotech ETF (NASDAQ:BBH) in the second quarter, Holdings Channel reports. The fund purchased 25,500 shares of the company’s stock, valued at approximately $5,183,000.

Other institutional investors have also made changes to their positions in the company. Empowered Funds LLC acquired a new position in VanEck Biotech ETF in the 4th quarter valued at approximately $38,000. Allworth Financial LP boosted its stake in shares of VanEck Biotech ETF by 255.0% during the 4th quarter. Allworth Financial LP now owns 426 shares of the company’s stock valued at $81,000 after buying an additional 306 shares during the period. JNBA Financial Advisors acquired a new stake in shares of VanEck Biotech ETF during the 2nd quarter valued at $122,000. Fifth Third Bancorp purchased a new position in shares of VanEck Biotech ETF during the 1st quarter valued at $127,000. Finally, Huntington National Bank purchased a new position in shares of VanEck Biotech ETF during the 4th quarter valued at $132,000. 32.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at VanEck Biotech ETF

In other VanEck Biotech ETF news, major shareholder Sardar Biglari sold 2,749 shares of the business’s stock in a transaction dated Thursday, July 16th. The stock was sold at an average price of $16.70, for a total value of $45,908.30. Following the transaction, the insider owned 3,549,961 shares in the company, valued at $59,284,348.70. The trade was a 0.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders sold a total of 10,493 shares of company stock worth $175,335 over the last ninety days.

VanEck Biotech ETF Stock Down 0.4%

NASDAQ BBH opened at $235.50 on Tuesday. VanEck Biotech ETF has a 1-year low of $160.91 and a 1-year high of $244.35. The firm’s fifty day simple moving average is $213.87 and its 200-day simple moving average is $197.38.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.